09 April 2025
Fostering career development through open science: Discover novel approaches in nanoformulation and retinal disease research
WATCH NOW
Missed our seminar on open science and how it empowers early-career research and scientific collaborations? Watch the recording now and catch all insights and the inspiring success stories of our opn2TALENTS and Molecules for collaboration programs!
Listen to our guest speaker, Carla Castellar Álvarez from Nanomol Technologies1, on developing a proof-of-concept for subcutaneous delivery of compounds with poor drug-like properties as part of a collaboration with Boehringer Ingelheim. Hear from Tarek Gensheimer, the winner of our first opn2TALENTS call, as he shares his journey to Boehringer and presents the latest advancements in organ-on-a-chip technology to explore the pathophysiology of retinal diseases2. By proposing their innovative ideas via opnMe, both advanced their scientific careers.
Start streaming now and discover opportunities for young researchers and scientific collaborations, and get inspired for your own scientific journey.
WATCH NOW
Subscribe to our newsletter to stay updated on our regular additions to opnMe.com.
About opnMe:
opnMe.com, the open science portal of Boehringer Ingelheim, fosters science and collaboration initiatives in areas of high unmet medical need. Our molecules are provided to the scientific community either free of charge as “Molecules to Order” or applied for via scientific research submissions as “Molecules for Collaboration”. With our “opn2EXPERTS” and “techMATCH” programs, we enlist scientific advice on key scientific topics to fuel further drug discovery and deliver novel solutions that benefit unmet patient needs. Our "opn2TALENTS" postdoc grants at one of our research sites offer opportunities for high-level talents to propose innovative approaches for precisely defined scientific questions.
About opnMe online seminars:
We invite you to watch the recordings of our online seminars on opnMe on the following topics:
- Cathepsin-C-inhibitor: Novel roles of Cathepsin C in human disease
- CNS-mental-health: Applying optogenetics to analyze neuronal networks in mental health
- MMP-13 antagonist: Assessing MMP-13 functions in osteoarthritis and aortic aneurysm
- PROTAC ACBI1: Illuminating the role of SMARCA2/4 in childhood cancer
- BCL6 Degrader: Elucidating the mechanism of small molecule induced protein degradation
References:
- Nanomol Technologies, S.L., Bellaterra, Barcelona, Spain - https://nanomol-tech.com/company
- Gensheimer T., Veermann D., van Oosten E., Segerink L., Garanto A., van der Meer A. Retina-on-chip: engineering functional in vitro models of the human retina using organ-on-chip technology. Lab Chip, 2025. DOI: 10.1039/D4LC00823E. Epub ahead of print.